Advertisement
Advertisement
U.S. markets open in 7 hours 43 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Helius Medical Technologies, Inc. (HSDT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.54-0.25 (-4.32%)
At close: 04:00PM EST
5.53 -0.01 (-0.18%)
After hours: 07:47PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close5.79
Open5.66
Bid0.00 x 1200
Ask0.00 x 1100
Day's Range5.53 - 5.81
52 Week Range5.53 - 34.00
Volume20,753
Avg. Volume20,626
Market Cap21.096M
Beta (5Y Monthly)0.91
PE Ratio (TTM)N/A
EPS (TTM)-8.16
Earnings DateNov 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est31.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for HSDT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Helius Medical Technologies, In
    Daily – Vickers Top Insider Picks for 12/02/2021The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • Benzinga

    CEO Of Helius Medical Tech Makes $300K Buy

    Dane Andreeff, CEO at Helius Medical Tech (NASDAQ:HSDT), made a large insider buy on November 12, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Andreeff purchased 37,500 shares of Helius Medical Tech at at a price of $8.00. The total transaction amounted to $300,000. Andreeff now owns a total of 6,142 of Helius Medical Tech worth, 50,732. Helius Medical Tech shares are trading up 1.85% at $8.26 at the time of

  • GlobeNewswire

    Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

    NEWTOWN, Pa., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (Helius), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff, President and Chief Executive Officer, and Jeffrey S. Mathiesen, Chief Financial Officer, will participate in 1x1 meetings at the 12th Annual Craig-Hallum Alpha Select Conference, being held virtually on Tuesday, November 16, 2021. Investors and attendees that would like to schedule a meeting with H

  • GlobeNewswire

    Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option

    NEWTOWN, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the closing of its previously announced underwritten public offering of 1,385,031 shares of its Class A common stock at a price to the public of $8.00 per share, for gross proceeds of approximately $11.1 million, including the full exercise of the underwriter’s over-allotment option to purchase addition

Advertisement
Advertisement